Stress and Skin – Scientifically Proven Connections
Cortisol, inflammatory cascades, and the brain-skin axis: What psychodermatology knows about the influence of chronic stress on the body's largest organ – and what conclusions can be drawn for evidence-based skincare.
- The Brain-Skin Axis: A Bidirectional System
- Cortisol and Skin Barrier: The Molecular Mechanisms
- Stress-Induced Inflammation and Inflammaging
- Acne, Psoriasis, and Co.: When Stress Triggers Skin Diseases
- Adaptogenic Active Ingredients in Cosmetics: Ashwagandha and Rhodiola Rosea
- Frequently Asked Questions
The connection between psychological well-being and skin condition has been popularly known for centuries: blushing from shame, pale skin from fright, rashes after stressful life events. What was long considered anecdotal observation is now the subject of an independent medical discipline – psychodermatology. It systematically investigates how the nervous system, endocrine system, and immune system jointly react to stress stimuli and what measurable consequences these reactions have for the skin.
Scientific research over the past two decades has identified a number of precise mechanisms: Cortisol and other stress hormones directly interfere with the lipid synthesis of the skin barrier, neurogenically released neuropeptides disrupt the immune homeostasis of the epidermis, and chronic inflammatory processes – summarized under the term inflammaging – demonstrably accelerate cutaneous aging. This article summarizes the current state of research, identifies the mechanisms involved, and classifies what follows for scientifically sound skincare.
The Brain-Skin Axis: A Bidirectional System
Skin and brain share a common embryonic origin: Both develop from the ectoderm, the outermost germ layer. This developmental biological kinship is reflected in an extraordinarily dense network, which researchers today refer to as the Brain-Skin Axis. The concept describes a bidirectional communication network in which the central nervous system continuously communicates with the skin via neuronal, endocrine, and immunological signaling pathways – and the skin, in turn, responds to these signals by releasing its own messenger substances.
A central element of this system is the Hypothalamic-Pituitary-Adrenal (HPA) axis. Upon perception of a stressor, the hypothalamus secretes Corticotropin-Releasing Hormone (CRH). This stimulates the pituitary gland to release adrenocorticotropic hormone (ACTH), which in turn stimulates the adrenal cortex to produce cortisol. Cortisol is the most important endogenous glucocorticoid receptor agonist and exerts widespread effects throughout the organism – including the skin.
It is noteworthy that the skin itself has a complete local HPA-equivalent system. Keratinocytes, melanocytes, and fibroblasts can locally synthesize CRH, ACTH, and cortisol and respond to stress stimuli at the cutaneous level without signals from the central nervous system being required. This discovery – significantly shaped by the work of Slominski and colleagues (2000, 2013) – has fundamentally changed the understanding of the cutaneous stress response: the skin is not only a target organ of the systemic stress system, it is an active participant.
This picture is complemented by the autonomic nervous system. Sympathetic nerve fibers densely innervate the skin and release catecholamines such as noradrenaline upon activation. Noradrenaline acts directly on keratinocytes and influences proliferation, differentiation, and inflammatory readiness there. At the same time, the sympathetic system controls the activity of the sebaceous glands, blood circulation, and the release of neuropeptides from sensory nerve fibers – all factors that directly influence visible skin quality.
The skin has its own local stress response system, which structurally corresponds to the systemic HPA axis. Keratinocytes can synthesize cortisol de novo – independently of signals from the brain. This makes the skin an autonomous stress organ, not just a passive target organ.
Cortisol and Skin Barrier: The Molecular Mechanisms
The skin barrier – primarily represented by the stratum corneum – is much more than a passive protective layer. It is a dynamically regulated system of corneocytes and intercellular lipids that controls transepidermal water loss (TEWL), fends off pathogenic microorganisms, and coordinates communication with the immune system. Its structural integrity critically depends on the orderly synthesis and secretion of lamellar bodies, which deposit ceramides, free fatty acids, and cholesterol into the intercellular compartment of the stratum corneum.
Cortisol interferes with this process at several levels. First, it inhibits the expression of enzymes required for ceramide synthesis – particularly serine palmitoyl transferase (SPT), the rate-limiting enzyme of de novo ceramide synthesis. Reduced ceramide levels decrease the lamellar structure of the lipid matrix in the stratum corneum and measurably increase TEWL. Clinical studies show that TEWL significantly increases under acute psychosocial stress and decreases again after stress normalization (Altemus et al., 2001).
Secondly, cortisol influences the expression of tight junction proteins, especially claudin-1 and occludin, which regulate paracellular water transport in the living epidermal part (stratum granulosum). Cortisol-mediated downregulation of these proteins increases epidermal permeability to external irritants and allergens – a mechanism that can explain why stress phases are often accompanied by increased skin sensitivity.
Thirdly, cortisol inhibits the proliferation and differentiation of keratinocytes. The epidermal renewal rate slows down, and the layering of the epithelium becomes more irregular. In chronic stress situations, where cortisol is continuously elevated, this can manifest as a rough, dull complexion – a clinically observable phenomenon that can now be explained by cell biology.
The barrier function of the skin is subject to a circadian rhythm: lipid synthesis and keratinocyte proliferation show distinct time-of-day dependencies. Chronic stress not only disrupts the absolute barrier performance but also its temporal timing – an aspect that NATURFACTOR®'s Chrono-Barrier Skin Science™ approach takes into account in its formulations.
Stress-Induced Inflammation and Inflammaging
In addition to the direct barrier effects of cortisol, there is a second, independent pathway: the stress-induced activation of inflammatory signaling pathways in the skin. This pathway primarily runs via the sympathetic nervous system and the cutaneous immune cell population and is mechanistically distinct from the cortisol pathway – although both systems interact closely in vivo.
Under psychological stress, sensory nerve fibers in the skin release neuropeptides – above all Substance P (SP) and Calcitonin Gene-Related Peptide (CGRP). Substance P binds to neurokinin-1 receptors on mast cells, keratinocytes, and dermal fibroblasts, inducing the release of proinflammatory cytokines such as IL-1β, IL-6, IL-8, and TNF-α. This process – referred to as neurogenic inflammation – is independent of systemic inflammatory stimuli and can occur locally in the skin without triggering a classic immune response.
Clinically, neurogenic inflammation manifests as redness, burning, increased sensitivity, and sometimes visible vasodilation. In individuals with pre-existing skin sensitivity or rosacea, even moderate psychological stress can trigger visible reactions via this mechanism.
More significant in the long term, however, is the concept of inflammaging – a term coined by Claudio Franceschi in 2000, which describes age-associated chronic low-grade inflammation. Chronic stress is considered one of the strongest non-genetic drivers of inflammaging: It permanently increases serum levels of pro-inflammatory cytokines (especially IL-6 and CRP), promotes the activation of the transcription factor NF-κB in skin cells, and accelerates telomere shortening in keratinocytes and fibroblasts – a direct cellular aging marker.
In the skin, inflammaging manifests as reduced collagen production (fibroblasts synthesize less collagen type I and III under chronic IL-6 influence), increased matrix metalloproteinase activity (especially MMP-1 and MMP-3, which degrade collagen and elastin), and impaired wound healing ability. Epidemiological data show that individuals with clinically diagnosed chronic stress burden or burnout symptoms show earlier and more pronounced signs of cutaneous aging on average than matched control groups (Epel et al., 2004).
"Chronic stress is not an abstract psychological construct – it leaves molecular traces in DNA methylation, telomere lengths, and the cytokine signature of skin cells."
Acne, Psoriasis, and Co.: When Stress Triggers Skin Diseases
The connection between stress and inflammatory skin diseases is well documented in clinical dermatology. Robust epidemiological and mechanistic data exist especially for acne vulgaris and psoriasis.
Acne Vulgaris
A prospective study by Chiu et al. (2003), conducted on Stanford University female students during and after exam periods, showed a statistically significant worsening of acne severity during high-stress phases – regardless of sleep quality, diet, and skincare habits. The mechanistic background is now largely understood: Cortisol and adrenal androgens, which are secreted together during stress, stimulate sebocytes (sebum-producing cells) to increase lipid synthesis. Increased sebum output, combined with stress-related hyperkeratinization of the follicular canal, promotes comedones and subsequent inflammatory lesions.
Substance P also plays a role here: It directly stimulates sebocytes to produce more sebum and simultaneously promotes the proliferation of Propionibacterium acnes (now: Cutibacterium acnes) in the anaerobic environment of the follicle. The cycle closes: stress → neuropeptide release → increased sebum production → bacterial growth → inflammation → visible acne lesions.
Psoriasis
Psoriasis is a T-cell-mediated autoimmune disease with a strong stress-responsive component. Retrospective and prospective studies consistently document that severe life events (loss of a loved one, divorce, job loss) are associated with increased flare frequency and intensity. The mechanism is complex: Stress-induced CRH and Substance P activate cutaneous T-cells and mast cells, increase IL-17 production (a key cytokine in psoriasis pathogenesis), and increase the epidermal proliferation rate.
Particularly relevant is the observation that psoriasis patients under stress show significantly higher serum levels of Neuropeptide Y and Substance P than healthy individuals under comparable stress – an indication of an altered neuroimmunological reaction pattern, which is probably genetically co-determined (Farber et al., 1986; Griffiths & Barker, 2007).
Atopic Dermatitis and Urticaria
The connection between atopic eczema and chronic urticaria and psychological stress is also well documented. In atopic dermatitis, stress is linked to disease exacerbations via Th2 activation and increased IgE sensitivity. Furthermore, cortisol impairs epidermal ceramide synthesis, which in already barrier-reduced atopic skin intensifies the vicious cycle of dehydration, itching, and scratching.
Psychodermatological interventions – particularly cognitive behavioral therapy and mindfulness-based stress reduction (MBSR) – show measurable improvements in skin condition in psoriasis and atopic dermatitis in randomized controlled trials. This supports the assumption of a causal, not just associative, stress-skin connection.
Adaptogenic Active Ingredients in Cosmetics: Ashwagandha and Rhodiola Rosea
The scientific understanding of the brain-skin axis has brought a new category of cosmetic active ingredients into focus in recent years: adaptogens. The term refers to plant extracts that increase biological stress resistance without stimulating or sedating in a specific direction. Pharmacologically, adaptogens are not a homogeneous class of substances – they encompass diverse mechanisms of action that, in sum, aim to normalize stress-activated signaling pathways.
Withania somnifera (Ashwagandha)
Ashwagandha has been established in Ayurvedic medicine for over 3,000 years. The main active ingredients – withanolides, especially withaferin A and withanolide D – are steroids with structural similarity to glucocorticoids. In in vitro studies, withaferin A inhibits the activation of NF-κB, reduces the synthesis of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), and protects keratinocytes from oxidative stress (Grover et al., 2012).
For topical application, cell studies show that Ashwagandha extracts can support collagen synthesis in dermal fibroblasts and increase the activity of superoxide dismutase (SOD) in skin cells – a relevant antioxidant mechanism that can counteract cortisol-induced oxidative stress. Systemic human studies also show a significant reduction in serum cortisol with oral supplementation (Chandrasekhar et al., 2012, n=64, RCT). Whether this effect is relevant with topical application remains open due to insufficient percutaneous bioavailability data – however, the anti-inflammatory and antioxidant in vitro effects remain substantial.
Rhodiola rosea (Rhodiola Rosea)
Rhodiola rosea grows in arctic and subarctic regions and has been used for centuries in traditional Scandinavian and Russian medicine as a stress-protective agent. The main active ingredients rosavin, rosarin, and salidroside act on several levels: They modulate the HPA axis by interacting with the stress hormone regulation system, inhibit the activity of monoamine oxidase (which affects stress-relevant neurotransmitters such as serotonin at a central level), and show pronounced antioxidant properties.
With regard to the skin, the antioxidant effects are particularly relevant: Salidroside protects keratinocytes in vitro from UVB-induced DNA damage and inhibits the activation of MMP-1 under oxidative stress (Ming et al., 2009). Since chronic stress increases the basic oxidative level in the skin, Rhodiola extract as a topical active ingredient can offer a complementary protective effect against stress-related skin damage.
For both adaptogens: their effect in cosmetics is not a pharmacological intervention in stress-related diseases, but a targeted support of cutaneous stress resilience – at the cellular level, within the scope of cosmetic efficacy claims. They can help keep the skin in a more balanced state under stress.
The effectiveness of adaptogenic extracts in cosmetics largely depends on extract quality, standardization of key active ingredients, and formulation concentration. Non-standardized crude extracts generally do not provide reproducible in-vitro results. NATURFACTOR®'s Bioactive Infusion Complex™ exclusively uses clinically characterized extracts standardized to marker compounds.
Frequently Asked Questions
Can short-term stress damage the skin as much as chronic stress?
Acute stress leads to measurable but generally reversible changes in the skin barrier. TEWL increases, and mast cell activity briefly rises. Chronic stress, however, causes persistent changes in cytokine signature, accelerates telomere erosion, and permanently reduces collagen synthesis. The more long-term damaging effect comes from chronic stress, even if episodic stress peaks—especially in already compromised skin—can trigger visible reactions.
Why does acne often worsen during exam periods or under professional pressure?
Stress stimulates the adrenal cortex to release cortisol and adrenal androgens (DHEA-S). Both promote sebum production in sebocytes. At the same time, the sympathetic nervous system releases substance P, which also directly increases sebaceous gland activity. More sebum in the follicular canal, combined with stress-induced hyperkeratinization, creates ideal conditions for the growth of Cutibacterium acnes—and thus for inflammatory acne lesions.
Are adaptogenic ingredients in cosmetics scientifically proven?
The data is two-fold. For the systemic effects of Ashwagandha and Rhodiola, randomized controlled human studies exist that demonstrate cortisol reduction and stress-protective effects. For topical use, primarily in-vitro data show anti-inflammatory, antioxidant, and collagen-stimulating properties. Clinical efficacy studies for topical formulations are still limited but are increasingly methodologically robust. Cosmetic application is based on these mechanisms—without implying pharmacological claims.
What does "neurogenic inflammation" mean and how does it differ from classic inflammation?
Classic inflammation is triggered by tissue damage, pathogens, or allergens and involves the immune system (neutrophils, macrophages, T-cells). Neurogenic inflammation, however, is triggered by the release of neuropeptides—particularly substance P and CGRP—from sensory nerve fibers, without primary tissue damage. It can be triggered by psychological stress, but also by heat or mechanical pressure. The result—redness, burning, swelling—is clinically similar, but the trigger mechanism is fundamentally different.
- Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev. 2000;80(3):979–1020.
- Altemus M, Rao B, Dhabhar FS, Ding W, Bhardwaj RS, Granstein R. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol. 2001;117(2):309–317.
- Chiu A, Chon SY, Kimball AB. The response of skin disease to stress. Arch Dermatol. 2003;139(7):897–900.
- Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA. 2004;101(49):17312–17315.
- Picardi A, Abeni D. Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom. 2001;70(3):118–136.
- Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–254.
- Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–271.
- Farber EM, Lanigan SW, Boer J. The role of cutaneous sensory nerves in the maintenance of psoriasis. Int J Dermatol. 1990;29(6):418–420.
- Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root. Indian J Psychol Med. 2012;34(3):255–262.
- Grover A, Shandilya A, Agrawal V, et al. Computational evidence to inhibition of human acetyl cholinesterase by withanolide A for Alzheimer treatment. J Biomol Struct Dyn. 2012;29(4):651–662.
- Ming DS, Hillhouse BJ, Guns ES, et al. Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res. 2005;19(9):740–743.
- Slominski AT, Manna PR, Bhatt CM, et al. On the role of classical and non-classical pathways of the cutaneous HPA equivalent. J Steroid Biochem Mol Biol. 2013;137:48–55.
- Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res. 2014;58(2-3):193–210.
- Theoharides TC, Enakuaa S, Sismanopoulos N, et al. Contribution of stress to the pathogenesis of atopic dermatitis. Ann Allergy Asthma Immunol. 2012;109(1):14–19.
